Drugs / \[68Ga\]-NOTA-hGZP

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04169321 Jun 2020 → Mar 2025 cancer, lymphoma Cytosite Biopharma Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as \[68Ga\]-NOTA-hGZP “\[68Ga\]-NOTA-hGZP is a PET imaging agent.” NCT04169321 ↗
Modality Diagnostic / imaging agent “\[68Ga\]-NOTA-hGZP is a PET imaging agent.” NCT04169321 ↗